Anthony Markham
- Transplantation top 2%
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers 6
- Pharmaceutical Science top 1%
- Hematology top 2%
-
- Asthma and respiratory diseases 13
-
- Chronic Lymphocytic Leukemia Research 9
-
- Lung Cancer Treatments and Mutations 9
- Respiratory and Cough-Related Research 9
-
- Mitochondrial Function and Pathology 9
-
- Heart Failure Treatment and Management 6
-
- Antibiotic Resistance in Bacteria 6
- Co-authors
- Susan J. KeamDiana FauldsKaren L. GoaRachel H. FosterDelyth ClemettCaroline M. PerryMichelle I. WildeBret Fulton
- Partner nations
- New ZealandUnited KingdomUnited States
In The Last Decade
Anthony Markham
163 papers receiving 8.9k citations
Peers
Comparison fields: 5 of 152
- Transplantation 199
- Oncology 1.8k
- Pharmaceutical Science 318
- Hematology 496
- Anesthesiology and Pain Medicine 244
Countries citing papers authored by Anthony Markham
This map shows the geographic impact of Anthony Markham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony Markham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony Markham more than expected).
Fields of papers citing papers by Anthony Markham
This network shows the impact of papers produced by Anthony Markham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony Markham. The network helps show where Anthony Markham may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anthony Markham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 41 | |
| 2 | 2021 | 57 | |
| 3 | 2021 | 50 | |
| 4 | 2021 | 30 | |
| 5 | 2021 | 80 | |
| 6 | 2021 | 54 | |
| 7 | 2020 | 31 | |
| 8 | 2020 | 111 | |
| 9 | 2020 | 45 | |
| 10 | 2016 | 19 | |
| 11 | 2001 | 19 | |
| 12 | 2000 | 290 | |
| 13 | 2000 | 21 | |
| 14 | 2000 | 36 | |
| 15 | Irbesartan. A Review of its Pharmacodynamic and Pharmacokinetic Properties and Therapeutic Use in the Management of Hypertension | 1999 | 3 |
| 16 | 1999 | 3 | |
| 17 | 1998 | 62 | |
| 18 | 1996 | 23 | |
| 19 | 1993 | 76 | |
| 20 | 1993 | 8 |
About Anthony Markham
Anthony Markham is a scholar working on Hematology, Physiology and Molecular Medicine, having authored 163 papers that have together received 9.3k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (13 papers), Chronic Lymphocytic Leukemia Research (9 papers), Lung Cancer Treatments and Mutations (9 papers), Respiratory and Cough-Related Research (9 papers), Mitochondrial Function and Pathology (9 papers), Heart Failure Treatment and Management (6 papers), Antibiotic Resistance in Bacteria (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). The work is most often cited by research in Transplantation (199 citations), Oncology (1.8k citations) and Pharmaceutical Science (318 citations). Anthony Markham has collaborated with scholars based in New Zealand, United Kingdom and United States. Frequent co-authors include Susan J. Keam, Diana Faulds, Karen L. Goa, Rachel H. Foster, Delyth Clemett, Caroline M. Perry, Michelle I. Wilde, Bret Fulton, Sean T. Duggan and Heather D. Langtry. Their work appears in journals such as Drugs, Biochemical Pharmacology, Drugs & Aging, Biochemical Society Transactions and British Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.